Journal of Animal Physiology and Animal Nutrition · 2014 · 37 citations · 31 references
Life SciencesNutritional SciencesPhysiologyMetabolic PhysiologyMetabolic RegulationNutritional BiochemistryAmino Acid MetabolismAmino Acid Metabolism DisordersGabaergic PharmacologyInsulin ResistanceMetabolic SyndromeOxidative Stress PhysiologyAmino AcidsBlood Glucose RegulationBody Weight RegulationMetabolic Response To DietOxidative Stress In DiabetesOxidative Stress In Metabolic DisordersOxidative Stress InjurySkeletal Muscle Fatty Acid Oxidation
Increased levels of plasma free amino acids (pFAAs) can disturb the blood glucose levels in patients with obesity, diabetes mellitus and metabolic syndrome (MS) and are associated with enhanced protein oxidation. Oxidation of proteins, especially in the muscles, can promote protein degradation and elevate the levels of pFAAs. Gamma-aminobutyric acid (GABA), a food additive, can reduce high-fat diet (HFD)-induced hyperglycaemia; however, the mechanisms remain unclear. The aim of this study was to evaluate the effects of GABA on protein oxidation and pFAAs changes. One hundred male C57BL/6 mice were randomly divided into five groups that were fed with control diet, HFD and HFD supplied with 0.2%, 0.12% and 0.06% GABA in drinking water for 20 weeks respectively. HFD feeding led to muscular oxidative stress, protein oxidation, pFAA disorders, hyperglycaemia and augmented plasma GABA levels. Treatment with GABA restored normally fasting blood glucose level and dose-dependently inhibited body weight gains, muscular oxidation and protein degradation. While medium and low doses of GABA mitigated HFD-induced pFAA disorders, the high dose of GABA deteriorated the pFAA disorders. Medium dose of GABA increased the levels of GABA, but high dose of GABA reduced the levels of plasma GABA and increased the activity of succinic semialdehyde dehydrogenase in the liver. Therefore, treatment with GABA mitigated HFD-induced hyperglycaemia probably by repairing HFD-induced muscular oxidative stress and pFAA disorders in mice. Our data also suggest that an optimal dose of GABA is crucial for the prevention of excess GABA-related decrease in the levels of pFAA and GABA as well as obesity.
31
Metabolite profiles and the risk of developing diabetes
Thomas J. Wang, Martin G. Larson, Ramachandran S. Vasan et al. · Nature Medicine · 2011 · 3.1K citations · Full text
Intracellular free amino acid concentration in human muscle tissue.
Jonas Bergström, Peter Fürst, L.‐O. Norée et al. · Journal of Applied Physiology · 1974 · 732 citations
Pengxiang She, Cynthia Van Horn, Tanya Reid et al. · American Journal of Physiology-Endocrinology and Metabolism · 2007 · 506 citations · Full text